Knight Therapeutics Inc. (TSX:GUD)
Canada · Delayed Price · Currency is CAD 9.85
+0.12 (1.23%)
Sep 11, 2026, 4:00 PM EST
Knight Therapeutics Market Cap
Knight Therapeutics has a market cap or net worth of CAD 967.58 million as of September 11, 2026. Its market cap has increased by 51.71% in one year.
Market Cap
967.58M
Enterprise Value
880.69M
Revenue
547.31M
Ranking
n/a
PE Ratio
65.66
Stock Price
9.85
ChartMarket Cap Chart
Since March 3, 2014, Knight Therapeutics's market cap has increased from 84.40M to 967.58M, an increase of 1,046.45%. That is a compound annual growth rate of 21.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 967.58M | 61.08% |
| Dec 31, 2025 | 600.70M | 12.16% |
| Dec 31, 2024 | 535.57M | -0.95% |
| Dec 29, 2023 | 540.73M | -7.35% |
| Dec 30, 2022 | 583.64M | -7.29% |
| Dec 31, 2021 | 629.56M | -9.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Green Thumb Industries | 2.24B |
| Cronos Group | 1.62B |
| DRI Healthcare Trust | 931.08M |
| Vireo Growth | 814.83M |
| Verano Holdings | 615.03M |
| Canopy Growth | 558.41M |
| Cresco Labs | 385.80M |
| Cardiol Therapeutics | 369.16M |